Dorsey Wright & Associates United Therapeutics Corp Transaction History
Dorsey Wright & Associates
- $403 Million
- Q4 2024
A detailed history of Dorsey Wright & Associates transactions in United Therapeutics Corp stock. As of the latest transaction made, Dorsey Wright & Associates holds 5,689 shares of UTHR stock, worth $1.77 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
5,689
Previous 5,769
1.39%
Holding current value
$1.77 Million
Previous $2.07 Million
2.9%
% of portfolio
0.5%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.7 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.7 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.38 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$858 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$766 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...